Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan

Sayer I Al-Azzam1, Karem H Alzoubi1, Salah AbuRuz2

  • 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

Insights

Drug-related problems (DRPs) are common in Jordanian hospital outpatient clinics, averaging 11.2 per patient. Clinical pharmacy services can help reduce these issues, especially in vulnerable patient groups.

Area of Science:

  • Pharmacology and Clinical Pharmacy
  • Health Services Research

Background:

  • Drug-related problems (DRPs) significantly impact healthcare quality, costs, and patient outcomes.
  • Optimizing drug therapy and preventing DRPs are crucial for improving patient care and reducing healthcare expenditure.

Purpose of the Study:

  • To identify and characterize the types, numbers, and frequencies of DRPs in outpatient settings within Jordanian hospitals.
  • To assess the association between DRPs and patient demographics or clinical conditions.

Main Methods:

  • A prospective study involving 2,898 patients across cardiology, endocrine, and respiratory outpatient clinics in five Jordanian hospitals from September 2012 to December 2013.
  • Clinical pharmacists assessed patients for DRPs using a validated pharmaceutical care manual.
  • Data collected included patient demographics, clinical conditions, and identified DRPs.

Main Results:

  • A total of 32,348 DRPs were identified, averaging 11.2 DRPs per patient.
  • The most frequent DRPs involved the need for additional monitoring, issues with adherence to self-care or non-pharmacological therapy, and lack of patient understanding of non-pharmacological advice.
  • Higher DRPs per patient were associated with older age, being unmarried, lower education levels, lack of health insurance, and specific conditions like hypertension, diabetes, and heart failure.

Conclusions:

  • Clinical pharmacy services are a vital strategy for mitigating DRPs in outpatient settings.
  • Specific patient populations, defined by age, socioeconomic factors, and comorbidities, are at higher risk for DRPs.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...